Dimension Therapeutics, Inc. 4
4 · Dimension Therapeutics, Inc. · Filed Feb 3, 2017
Insider Transaction Report
Form 4
Wadsworth Samuel C.
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2017-02-01+60,000→ 60,000 totalExercise: $1.90Exp: 2027-01-31→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]This stock option vests in forty-eight (48) equal monthly installments beginning on January 18, 2017.